Orizuru Therapeutics

Developer of stem-cell-derived organoid models for drug discovery

placeKyoto, Kyoto, Japan calendar_todayFounded 2021 groups60 employees language orizuru-therapeutics.com

Registered entities

Innovation

16 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 469 times.

YearFilings
20203
20216
20227
202311
202410
202510
20263

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon